Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

June 8, 2016

Primary Completion Date

October 3, 2018

Study Completion Date

October 3, 2018

Conditions
Colorectal Neoplasms
Interventions
DRUG

BI 695502

DRUG

Avastin

Trial Locations (46)

21029

Vinnytsia Regional Clinical Oncological Dispensary, Vinnytsia

23226

Virginia Cancer Institute, Richmond

25006

Treatment-Diagnostic CTR of Private Enterprise, Kirovohrad, Kirovohrad

38011

Poltava Regional Clinical Oncological Dispensary, Poltava, Poltava

40022

Sumy Regional Oncology Center, Sumy

41101

Ashland Bellefonte Cancer Center, Ashland

44710

Aultman Hospital, Canton

45242

Oncology Hematology Care, Cincinnati

46010

Hospital Clínico de Valencia, Valencia

48109

University of Michigan Health System, Ann Arbor

49102

"Munic.Instit.City Clin.Hosp.#4 of Dnipro City Council", Dnipropetrovsk

50048

CI Kryvyi Rih Oncological Dispensary of DRC, Kryvyi Rih, Dnipropetrovsk

58013

CI Chernivtsi RC Oncological Dispensary Bukovinian SMU, Chernivtsi

61037

CI of PH Kharkiv CCH #2, Kharkiv

63110

Washington University School of Medicine, St Louis

75028

Texas Oncology, P.A., Flower Mound

75150

Texas Oncology, PA, Mesquite

75701

Tyler Hematology-Oncology, PA, Tyler

75702

Texas Oncology, P.A., Tyler

76018

Regional Clinical Oncological Dispensary, Ivano-Frankivsk, Ivano-Frankivsk

77030

Oncology Consultants, P.A., Houston

77598

Texas Oncology, P.A., Deke Slayton Cancer Center, Webster

78217

Texas Oncology-San Antonio Northeast, San Antonio

78229

Texas Oncology San Antonio Medical Center, San Antonio

78705

Texas Oncology, P.A., Austin

79031

CI of LRC Lviv Onco.Reg.Treat.&Diag.Cent., Lviv

79106

Texas Oncology, PA,, Amarillo

79606

Texas Oncology, P.A., Abilene

80218

Rocky Mountain Cancer Centers, Denver

85054

Mayo Clinic-Arizona, Phoenix

92801

Pacific Cancer Medical Center, Inc., Anaheim

The Oncology Institute of Hope and Innovation, Anaheim

97225

Northwest Cancer Specialists PC, Portland

97477

Willamette Valley Cancer Institute and Research Center, Springfield

75042-5788

Texas Oncology, P.A., Garland

78503-1298

Texas Oncology, P.A., McAllen

260-8717

Chiba Cancer Center, Chiba, Chiba

791-0280

National Hospital Organization Shikoku Cancer Center, Ehime, Matsuyama

060-8648

Hokkaido University Hospital, Hokkaido, Sapporo

660-8511

Japan Organization of Occupational Health and Safety Kansai Rosai Hospital, Hyogo, Amagasaki

761-0793

Kagawa University Hospital, Kagawa, Kita-gun

565-0871

Osaka University Hospital, Osaka, Suita

135-8550

Jananese Foundation for Cancer Research, Tokyo, Koto-ku

08035

Hospital Vall d'Hebron, Barcelona

08907

Hospital Duran i Reynals, L'Hospitalet de Llobregat

03022

National Institute of Cancer, Kyiv

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02776683 - Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter